News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Julie Cahill, MD, VP, Consulting and Medical Director Services at Zipher and Brand Insights Contributor

Advertisement

Articles by Julie Cahill, MD, VP, Consulting and Medical Director Services at Zipher and Brand Insights Contributor

Fostering Data Generation to Build the Value Story: An Opportunity for Medical Affairs to Move the Needle

ByJulie Cahill, MD, VP, Consulting and Medical Director Services at Zipher and Brand Insights Contributor
February 3rd 2022
Advertisement

Latest Updated Articles

  • Fostering Data Generation to Build the Value Story:  An Opportunity for Medical Affairs to Move the Needle
    Fostering Data Generation to Build the Value Story: An Opportunity for Medical Affairs to Move the Needle

    Published: February 3rd 2022 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Brent Saunders: Eyeing New Horizons

2

TrumpRX Has a Blind Spot and It Can Redefine Patient Access

3

The GLP-1 Gold Rush

4

FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies

5

Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us